(HealthDay)—For patients with acute coronary syndrome (ACS), treatment with direct oral anticoagulants (DOACs) in addition to antiplatelet therapy (APT) appears efficacious for those with ST-segment elevation myocardial ...
Feb 9, 2018
0
3
(HealthDay)—Supplementation with omega-3 fatty acids is not associated with fatal or nonfatal coronary heart disease or major vascular events, according to a review published online Jan. 31 in JAMA Cardiology.
Feb 1, 2018
0
4
(HealthDay)—For adolescents with depression who declined or quickly stopped using antidepressants, a brief cognitive behavioral therapy (CBT) program is cost-effective, according to a study published online Jan. 19 in Pediatrics.
Jan 19, 2018
0
8
(HealthDay)—The risk of psychotic experiences is increased with cannabis use during adolescence, according to a study published online Jan. 17 in JAMA Psychiatry.
Jan 19, 2018
0
19
(HealthDay)—Weaning to an extensively hydrolyzed casein formula is not associated with reduced incidence of type 1 diabetes among at-risk infants, according to a study published in the Jan. 2 issue of the Journal of the ...
Jan 4, 2018
0
3
(HealthDay)—Paternal use of selective serotonin reuptake inhibitors (SSRIs) before conception is associated with increased risk of attention-deficit/hyperactivity disorder (ADHD) in offspring, according to a study published ...
Dec 11, 2017
1
0
(HealthDay)—Sport sampling in childhood may be associated with higher physical activity (PA) levels during adolescence, according to a study published online Nov. 13 in Pediatrics.
Nov 15, 2017
0
1
(HealthDay)—Most people complete treatment for latent tuberculosis (TB) without direct observation, according to a study published online Nov. 6 in the Annals of Internal Medicine.
Nov 7, 2017
0
0
(HealthDay)—For patients with chronic valvular heart disease, white matter hyperintensity (WMH) volume is associated with mean right atrial (RA) pressure, according to a study published online Nov. 6 in JAMA Neurology.
Nov 7, 2017
0
0
(HealthDay)—Long-term proton pump inhibitor (PPI) use is associated with increased risk of gastric cancer (GC) even after Helicobacter pylori (HP) eradication therapy, according to a study published online Oct. 31 in Gut.
Nov 2, 2017
0
0
